Modulating near-infrared persistent luminescence of core-shell nanoplatform for imaging of glutathione in tumor mouse model

Persistent Luminescence Lifetime-Based Near-Infrared Nanoplatform via Deep Learning for High-Fidelity Biosensing of Hypochlorite

In light of deep tissue penetration and ultralow background, near-infrared (NIR) persistent luminescence (PersL) bioprobes have become powerful tools for bioapplications. However, the inhomogeneous signal attenuation may significantly limit its application for precise biosensing owing to tissue absorption and scattering. In this work, a PersL lifetime-based nanoplatform via deep learning was proposed for high-fidelity bioimaging and biosensing in vivo. The persistent luminescence imaging network (PLI-Net), which consisted of a 3D-deep convolutional neural network (3D-CNN) and the PersL imaging system, was logically constructed to accurately extract the lifetime feature from the profile of PersL intensity-based decay images. Significantly, the NIR PersL nanomaterials represented by Zn1+xGa2-2xSnxO4: 0.4 % Cr (ZGSO) were precisely adjusted over their lifetime, enabling the PersL lifetime-based imaging with high-contrast signals. Inspired by the adjustable and reliable PersL lifetime imaging of ZGSO NPs, a proof-of-concept PersL nanoplatform was further developed and showed exceptional analytical performance for hypochlorite detection via a luminescence resonance energy transfer process. Remarkably, on the merits of the dependable and anti-interference PersL lifetimes, this PersL lifetime-based nanoprobe provided highly sensitive and accurate imaging of both endogenous and exogenous hypochlorite. This breakthrough opened up a new way for the development of high-fidelity biosensing in complex matrix systems.

Time-resolved fluorescence nanoprobe of acetylcholinesterase based on ZnGeO:Mn luminescence nanorod modified with metal ions

A novel time-resolved fluorescence nanoprobe (PBMO, PLNR-BSA-Mn2+-OPD) is fabricated for the label-free determination of acetylcholinesterase (AChE). The ZnGeO:Mn persistent luminescence nanorod (PLNR) and Mn(II) are, respectively, exploited as the signal molecule and quencher to construct the PBMO nanopobe using bovine serum albumin (BSA) as the surface-modified shell and o-phenylenediamine (OPD) as the reducing agent. In the presence of H2O2, the persistent luminescence of PBMO at 530 nm is enhanced remarkably within 30 s due to the oxidation of Mn(II). H2O2 can react with thiocholine (TCh), which is produced through the enzymatic degradation of acetylcholine (ATCh) by AChE. The PBMO nanoprobe is successfully applied to the determination of AChE in the linear range of 0.08-10 U L-1, with a detection limit of 0.03 U L-1 (3σ/s). The practicability of this PBMO nanoprobe is confirmed by accurately monitoring AChE contents in human serum samples, giving rise to satisfactory spiking recoveries of 96.2-103.6%.

Perspective and Prospects on persistent luminescent nanoparticles for biological imaging and tumor therapy

Persistent luminescent nanoparticles (PLNPs) are photoluminescent materials that can still emit luminescence after the cessation of the excitation light source. In recent years, due to their unique optical properties, the PLNPs have attracted extensive attention in the biomedical field. Since the PLNPs effectively eliminate autofluorescence interference from biological tissues, many researchers have contributed a lot of work in the fields of biological imaging and tumor therapy. This article mainly introduces the synthesis methods of the PLNPs and their progress in the application of biological imaging and tumor therapy, as well as the challenges and development prospects.

Dual-Triggered Near-Infrared Persistent Luminescence Nanoprobe for Autofluorescence-Free Imaging-Guided Precise Therapy of Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a common, chronic, and highly disabling autoimmune disease characterized by difficult treatment, long disease duration, and easy recurrence. The development and application of high-sensitivity theranostic probes for RA that will facilitate precise monitoring of disease progression and enable effective treatment are currently hotspots in the field of RA theranostics. In this study, mZMI@HA, a dual-triggered theranostics nanoprobe, is constructed based on near-infrared persistent luminescence nanoparticles (NIR-PLNPs) for precise RA treatment and therapeutic evaluation. This is the first reported use of high-sensitivity autofluorescence-free imaging based on NIR-PLNPs for precise RA treatment and therapeutic evaluation. Compared with the NIR fluorescence imaging probe-indocyanine green, the signal-to-background ratio of persistent luminescence (PersL) imaging is improved nearly 14-fold. Using PersL imaging to guide photothermal therapy and controllable drug release through NIR/pH-responsiveness, the progress of collagen-induced RA is relieved. Additionally, the therapeutic evaluation of RA by PersL imaging is consistent with clinical micro-computed tomography and histological analyses. This study demonstrates the potential of NIR-PLNPs for high-sensitivity imaging-guided RA treatment, providing a new strategy for RA precise theranostics.

A persistent luminescence resonance energy transfer-based molecular beacon probe for the highly sensitive detection of microRNA in biological samples

Herein, a time-resolved luminescence resonance energy transfer (TR-LRET) molecular beacon (MB) probe employing persistent luminescence nanoparticles (PLNPs) as the energy donors was first constructed, and further designed for microRNA21 (miR21) sensing. This probe (named as PLNPs-MB) was facilely fabricated by covalent bioconjugation between poly-(acrylic acid) (PAA) modified near-infrared (NIR) emissive PLNPs i.e. ZnGa₂O₄:Cr³⁺ and functionalized MB oligonucleotide (5'-NH₂ and 3'-BHQ3). Accordingly, PLNPs and BHQ3 were in close proximity to each other, leading to the occurrence of LRET and obvious persistent luminescence (PL) quenching. In the presence of miR21, loop of the PLNP-MB was hybridized, accompanying BHQ3 away from PLNPs and the restraint of LRET process. As a result, PL of the PLNPs was recovered, which built the foundation of miR21 quantification. The probe provided a linear response range from 0.1 to 10 nM for miR21 detection. Quantification limit of this probe was competitive and about 1-2 orders of magnitude lower than that of other reported MB probes for nucleic acid. Moreover, the proposed probe was successfully adopted for miR21 detection in biological fluids (human serum, cell extraction). This work also provided a sensitive detection nanoplatform for other targets through modifying diverse MBs onto the surface of PLNPs.

Recent Progress of Near-Infrared Persistent Phosphors in Bio-related and Emerging Applications

Near-infrared persistent phosphors (NIR-PPs) are an emerging category of luminescent materials that can continuously emit NIR luminescence with super-long decay time of minutes, hours, or even days after the excitation ceases. Their unique excitation-free long-lasting afterglow, together with the NIR emission, has not only attracted wide research interests in the areas of photochemistry, photophysics, spectroscopy, and materials science, but also stimulated advanced applications in biosensing, bioimaging, biomedicine, and therapy in the past decade. Beyond these bio-related applications, the active research field triggers a number of novel applications recently. In this review, a brief outline of NIR-PPs including the luminescence mechanism, main material systems, and how they were applied into various fields was depicted. Particular emphasis was put on the emerging applications outside the field of biology. Future perspectives in this exploration research area were also presented. We hope this review can help researchers grab the latest information in the fast-growing field of NIR-PPs.

Multiple emission bands NIR-persistent luminescence mSiO2@Zn0.6Ca0.4Ga2O4:Cr3+,Yb3+ nanoparticles for biological applications

Persistent luminescence nanoparticles (PLNPs) emitting in the NIR window (700-1700 nm) have shown great promise in the field of fluorescence imaging due to their unique properties, including the absence of in situ excitation and low optical scattering in tissues. However, they are still facing some challenges, such as irregular shape, wide size distribution and poor persistent luminescence performance. Here, we report a facile mesoporous template method for synthesizing mSiO₂@Zn_0.6Ca_0.4Ga₂O₄:Cr³⁺,Yb³⁺ (mSiO₂@ZCGO) persistent luminescent nanoparticles, which show a regular morphology and a size of about 69 nm. In addition, these nanocrystals exhibit persistent luminescence in multi-NIR windows, the first infrared window (∼696 nm of Cr³⁺ emission) and second infrared window (∼1000 nm of Yb³⁺ emission). Under illumination of a 254 nm UV lamp for 10 min, the persistent time of Cr³⁺ ions and Yb³⁺ ions lasted more than 120 min and 10 min, respectively. In particular, the NIR persistent emission of mSiO₂@ZCGO could be stimulated by soft X-ray, which is beneficial to long-term imaging in deep tissues. The optical penetration length of Yb³⁺ ions persistent luminescence was evaluated to be 2.8 mm. These results demonstrate the great promise of mSiO₂@ZCGO for deep-tissue bio-imaging.

Raspberry-Like Mesoporous Zn1.07Ga2.34Si0.98O6.56:Cr0.01 Nanocarriers for Enhanced Near-Infrared Afterglow Imaging and Combined Cancer Chemotherapy

Near-infrared (NIR) persistent luminescence (PersL) nanoparticles based on trivalent chromium-doped gallates (ZGO) as nanocarriers show great potential for theranostics, owing to their autofluorescence-free background and deep tissue penetration. However, high drug loading capacity of ZGO nanocarriers remains a big challenge. Herein, raspberry-like mesoporous Zn_1.07Ga_2.34Si_0.98O_6.56:Cr_0.01 (designated as Si-ZGO) is first developed via a unique silica-assisted targeted etching strategy. The composition, morphology, NIR PersL capacities, and drug loading/releasing abilities of Si-ZGO have been explored. These results exhibit that Si-ZGO possess multiple inspiring characteristics including (i) spherical raspberry-like mesoporous morphology with a large cavity (total pore size ∼5.0 nm) and high specific surface area (∼80.653 m²·g^-1), promising excellent drug loading capacity (∼62 wt %); (ii) tunable sizes from 80 to 180 nm and improved aqueous-dispersibility, facilitating cellular uptake and permeation and retention (EPR) effect; (iii) new deep traps related to oxygen vacancies, achieving the brighter NIR PersL. These outstanding merits enable the further nanosystem (DOX-BSA@Si-ZGO) for proof-of-concept theranostics excellent chemotherapy effect, tumor-specific trackable ability, and pronounced NIR afterglow imaging in vivo. This work demonstrates the great potentials of Si-ZGO nanorasperries as a multifunctional theranostics platform, even more it hopefully could inspire other constructions of advanced functional materials.

Ultrasensitive aptamer-based protein assays based on one-dimensional core-shell nanozymes

In enzyme-based immunoassys, the use of natural enzyme has been remarkably restricted by the inconvenience in preparation and storage, especially for point-of-care testing. Nanozymes, which can mimic the functions of natural enzymes, have been regarded as promising alternatives due to their robust stability and convenience in fabrication. Here we fabricated one-dimensional Fe₃O₄@C core-shell nanostructures via a solvent-thermal method. Thus prepared nanocomposites showed excellent peroxidase-like activity, capable of catalyzing chromogenic substrates into colored products in the presence of H₂O₂. We then developed a nanozyme-linked aptamer sorbent assay (NLASA) in a sandwich format, in which the as-prepared Fe₃O₄@C nanowires were employed as catalytic labels for colorimetric detection by naked eyes. In the detection of platelet-derived growth factor BB (PDGF-BB), this assay reliably exhibited detection limits as low as 10 fM, with a working range from 10 fM to 100 nM. By incorporating G-quadruplex-hemin DNAzyme with Fe₃O₄@C nanowires, the detection limit could be further lowered to 50 aM. The detection limit of PDGF-BB in 50% human serum was 100 fM. This ultrasensitive, cost-effective and easy-to-operate sensing platform offers new opportunities for protein detection in clinical diagnosis.